Simcere Pharmaceutical Group Limited (2096.HK)
HKD 7.66
(0.26%)
HKD 7.66
(0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.6 Billion | 6.31 Billion | 4.99 Billion | 4.5 Billion | 5.03 Billion | 4.51 Billion |
| Cost of Revenue | 1.62 Billion | 1.32 Billion | 1.07 Billion | 899.92 Million | 888.48 Million | 771.19 Million |
| Gross Profit | 4.98 Billion | 4.99 Billion | 3.91 Billion | 3.6 Billion | 4.14 Billion | 3.74 Billion |
| Operating Expenses | 4.27 Billion | 4.42 Billion | 3.7 Billion | 3.01 Billion | 3 Billion | 2.9 Billion |
| Selling, General and Administrative Expenses | 2.84 Billion | 2.84 Billion | 2.41 Billion | 1.98 Billion | 2.15 Billion | 2.35 Billion |
| Research and Development Expenses | 1.56 Billion | 1.72 Billion | 1.41 Billion | 1.14 Billion | 716.41 Million | 447.14 Million |
| Other Expenses | -135 Million | -154.52 Million | -132.16 Million | -104.93 Million | 132.76 Million | 12.05 Million |
| Cost and Expenses | 5.89 Billion | 5.74 Billion | 4.78 Billion | 3.91 Billion | 3.89 Billion | 3.67 Billion |
| Operating Income | 711.8 Million | 862.5 Million | 687.9 Million | 565.66 Million | 1.17 Billion | 941.94 Million |
| Interest Expense | 34.56 Million | 34.4 Million | 70.84 Million | 133.72 Million | 115.95 Million | 47.53 Million |
| Income Tax Expense | 26.08 Million | -40.47 Million | -97.12 Million | 140.8 Million | 78.19 Million | 195.35 Million |
| Earnings before Tax | 740.03 Million | 888.15 Million | 1.4 Billion | 805.08 Million | 1.08 Billion | 929.04 Million |
| Net Income | 714.76 Million | 930.86 Million | 1.5 Billion | 669.53 Million | 1 Billion | 733.68 Million |
| Earnings Per Share Basic | 0.27 | 0.40 | 0.58 | 0.26 | 0.39 | 0.28 |
| Earnings Per Share Diluted | 0.27 | 0.40 | 0.58 | 0.26 | 0.39 | 0.28 |
| Weighted Average Shares Outstanding | 2.6 Billion | 2.61 Billion | 2.6 Billion | 2.6 Billion | 2.6 Billion | 2.6 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.6 Billion | 2.62 Billion | 2.61 Billion | 2.6 Billion | 2.6 Billion | 2.6 Billion |
| Gross Margin | 0.75 | 0.79 | 0.78 | 0.80 | 0.82 | 0.83 |
| EBIT Margin | 0.16 | 0.17 | 0.19 | 0.17 | 0.27 | 0.23 |
| Profit Margin | 0.11 | 0.15 | 0.30 | 0.15 | 0.20 | 0.16 |
| EBITDA | 1.08 Billion | 1.08 Billion | 939.7 Million | 787.99 Million | 1.36 Billion | 1.01 Billion |
| Earnings Before Tax Margin | 0.11 | 0.14 | 0.14 | 0.13 | 0.23 | 0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.55 Billion | 1.55 Billion | 1.61 Billion | 6.6 Billion | 1.61 Billion | 1.68 Billion |
| Cost of Revenue | 325.79 Million | 325.79 Million | 402.81 Million | 1.62 Billion | 402.81 Million | 409.01 Million |
| Gross Profit | 1.23 Billion | 1.23 Billion | 1.21 Billion | 4.98 Billion | 1.21 Billion | 1.28 Billion |
| Operating Expenses | 984.88 Million | 984.88 Million | 2.01 Billion | 4.25 Billion | 2 Billion | 124.44 Million |
| Selling, General and Administrative Expenses | 692.3 Million | 692.3 Million | 675.9 Million | - | 675.9 Million | 751.49 Million |
| Research and Development Expenses | 283.06 Million | 283.06 Million | 402.66 Million | - | 402.66 Million | 387.94 Million |
| Other Expenses | 9.52 Million | 9.52 Million | 932.96 Million | 5.07 Million | - | - |
| Cost and Expenses | 1.31 Billion | 1.31 Billion | 2.41 Billion | 5.88 Billion | 2.41 Billion | 533.46 Million |
| Operating Income | 246.08 Million | 246.08 Million | -800.1 Million | 711.8 Million | 175.99 Million | 179.42 Million |
| Interest Expense | - | - | - | 34.56 Million | - | - |
| Income Tax Expense | 19.04 Million | 19.04 Million | 12.62 Million | 26.08 Million | 12.62 Million | 25.67 Million |
| Earnings before Tax | 247.34 Million | 247.34 Million | -792.57 Million | 740.03 Million | -792.57 Million | 1.16 Billion |
| Net Income | 228.3 Million | 228.3 Million | -779.94 Million | 714.76 Million | -779.94 Million | 1.13 Billion |
| Earnings Per Share Basic | 0.09 | 0.09 | -0.30 | - | -0.30 | 0.43 |
| Earnings Per Share Diluted | 0.09 | 0.09 | -0.30 | - | -0.30 | 0.43 |
| Weighted Average Shares Outstanding | 2.55 Billion | 2.55 Billion | 2.59 Billion | 2.6 Billion | 2.59 Billion | 2.64 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.55 Billion | 2.55 Billion | 2.59 Billion | 2.6 Billion | 2.59 Billion | 2.62 Billion |
| Gross Margin | 0.79 | 0.79 | 0.75 | 0.75 | 0.75 | 0.76 |
| EBIT Margin | 0.22 | 0.22 | 0.14 | - | 0.14 | 0.14 |
| Profit Margin | 0.15 | 0.15 | -0.48 | 0.11 | -0.48 | 0.67 |
| EBITDA | 345.55 Million | 345.55 Million | 228.56 Million | - | 228.56 Million | 233.99 Million |
| Earnings Before Tax Margin | 0.16 | 0.16 | -0.50 | 0.11 | 0.11 | 0.11 |
2601
605111
1785
GMBL
600612
DTSQU